In the first half of 2026, China's brain-computer interface (BCI) industry is transitioning from top-level design to implementation and acceleration. In March, BCI was included in the government work report alongside future industries like quantum technology and 6G, marking it as a key area for development. The 14th Five-Year Plan also identifies BCI as a priority sector, prompting national departments to advance supportive policies and clarify standards and regulations.
This push began in July 2025 with the issuance of a national-level document aimed at fostering innovation in the BCI sector, setting ambitious goals for 2027 and 2030. However, as of the end of 2025, the industry faces structural challenges, including a lack of standards and payment mechanisms. The first half of 2026 marks a turning point, with BCI being formally recognized in government planning and the establishment of a regulatory framework.
In June 2026, the National Medical Products Administration released guidelines for classifying BCI medical devices, which will facilitate product registration and insurance coverage. State-owned enterprises are evolving from laboratory collaborations to becoming integrators of the industry chain. By June 2026, there were 64 financing cases in the BCI field, totaling 7.253 billion yuan, significantly surpassing the previous year's performance.
Editor's Note
The rapid development of China's brain-computer interface industry highlights the increasing importance of government support and corporate involvement in emerging technologies. As the sector matures, it will be crucial for stakeholders to navigate regulatory frameworks and establish standards to ensure sustainable growth and innovation. The integration of state-owned enterprises into the BCI landscape may also reshape competitive dynamics within the industry.
Leave a comment